|
Volumn 77, Issue 11, 1996, Pages 2413-2414
|
Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in Stages IIIa and IIIb nonsmall cell lung cancer: A meta- analysis
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
ETOPOSIDE;
VINCA ALKALOID;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER STAGING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
HUMAN;
LUNG NON SMALL CELL CANCER;
MAJOR CLINICAL STUDY;
META ANALYSIS;
PRIORITY JOURNAL;
RADIOSENSITIZATION;
RANDOMIZED CONTROLLED TRIAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BIAS (EPIDEMIOLOGY);
CARCINOMA, NON-SMALL-CELL LUNG;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
COMBINED MODALITY THERAPY;
ETOPOSIDE;
HUMANS;
LUNG NEOPLASMS;
META-ANALYSIS;
ODDS RATIO;
RANDOMIZED CONTROLLED TRIALS;
RISK;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
VINCA ALKALOIDS;
|
EID: 0029899558
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1097-0142(19960601)77:11<2413::AID-CNCR34>3.0.CO;2-Y Document Type: Article |
Times cited : (44)
|
References (0)
|